AI app aims to empower kidney dialysis patients

NCT ID NCT07300761

Not yet recruiting Symptom relief Sponsor: Ataturk University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a smartphone app with artificial intelligence can help people on hemodialysis take better care of themselves. The app provides education on diet, fluid intake, and fistula care, and sends reminders. 76 patients will be randomly assigned to use the app or receive standard care for six weeks, and researchers will measure changes in self-care behaviors and blood test results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-supported mobile education application
What this could lead to: If it works, this could give hemodialysis patients a practical tool to better manage their own care, potentially reducing complications and improving quality of life.
What could go wrong: This is a small, early-stage trial (76 people) testing a behavioral app, not a drug. The results may not be generalizable, and the app's impact on health outcomes is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE REQUIRING HEMODIALYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMODIALYSIS PATIENT PATIENT EDUCATION SELF CARE

More trials for these conditions

Other studies related to the condition(s) this trial covers.